Nureca Ltd

Nureca Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Nureca Ltd

₹ 289 -1.28%
25 Apr - close price
nureca.com BSE: 543264 NSE : NURECA
About

Incorporated in 2016, Nureca Ltd is in the business of home healthcare and wellness products[1]

Key Points

Business Overview:[1][2]
NL is a D2C healthcare and wellness company with a USFDA, CE, FSSAI, and ISO 13485-certified product range of over 150 SKUs across different categories. It supports diagnosis, treatment, and prevention of illness through monitoring & analysis of health data.

Website BSE NSE
  • Market Cap ₹ 289 Cr.
  • Current Price ₹ 289
  • High / Low ₹ 469 / 252
  • Stock P/E 352
  • Book Value ₹ 197
  • Dividend Yield 0.00 %
  • ROCE -6.27 %
  • ROE -5.37 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Earnings include an other income of Rs.13.9 Cr.
  • Promoter holding has decreased over last 3 years: -6.76%
  • Working capital days have increased from 111 days to 160 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: E-Commerce/App based Aggregator Industry: Trading

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
59.47 31.84 119.48 46.94 48.08 41.05 25.53 36.78 27.79 21.23 21.23 31.35 22.37
51.47 27.47 72.39 40.91 42.97 43.78 31.25 41.69 28.71 24.69 24.13 29.97 26.62
Operating Profit 8.00 4.37 47.09 6.03 5.11 -2.73 -5.72 -4.91 -0.92 -3.46 -2.90 1.38 -4.25
OPM % 13.45% 13.72% 39.41% 12.85% 10.63% -6.65% -22.41% -13.35% -3.31% -16.30% -13.66% 4.40% -19.00%
0.71 1.28 2.14 2.11 1.74 1.71 1.17 1.89 1.90 2.15 2.67 3.20 5.90
Interest 0.04 0.38 0.22 0.12 0.11 0.29 0.14 0.10 0.11 0.10 0.12 0.08 0.11
Depreciation 0.18 0.07 0.16 0.31 0.42 0.59 0.61 0.62 0.60 0.56 0.58 0.59 0.59
Profit before tax 8.49 5.20 48.85 7.71 6.32 -1.90 -5.30 -3.74 0.27 -1.97 -0.93 3.91 0.95
Tax % 25.80% 25.19% 25.92% 29.57% 25.16% 26.32% 22.08% 22.73% -11.11% 22.34% 23.66% 25.83% 82.11%
6.30 3.89 36.20 5.43 4.73 -1.40 -4.13 -2.89 0.30 -1.53 -0.71 2.89 0.17
EPS in Rs 8.40 3.89 36.20 5.43 4.73 -1.40 -4.13 -2.89 0.30 -1.53 -0.71 2.89 0.17
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
61.90 99.43 213.45 255.55 111.32 96.18
52.85 89.74 151.91 200.05 126.33 105.41
Operating Profit 9.05 9.69 61.54 55.50 -15.01 -9.23
OPM % 14.62% 9.75% 28.83% 21.72% -13.48% -9.60%
0.09 0.06 2.82 7.70 7.11 13.92
Interest 0.24 0.77 1.60 0.74 0.45 0.41
Depreciation 0.06 0.37 0.42 1.48 2.39 2.32
Profit before tax 8.84 8.61 62.34 60.98 -10.74 1.96
Tax % 29.52% 25.78% 25.60% 26.27% 23.18%
6.23 6.40 46.37 44.96 -8.25 0.82
EPS in Rs 6,230.00 6,400.00 46.37 44.96 -8.25 0.82
Dividend Payout % 0.00% 0.00% 4.31% 6.67% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 4%
TTM: -27%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 110%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -41%
1 Year: -13%
Return on Equity
10 Years: %
5 Years: %
3 Years: 17%
Last Year: -5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 0.01 0.01 10.00 10.00 10.00 10.00
Reserves 7.94 14.92 153.10 193.20 184.88 187.04
0.43 9.78 3.89 4.41 3.33 2.76
15.14 9.17 18.76 11.52 8.38 9.19
Total Liabilities 23.52 33.88 185.75 219.13 206.59 208.99
0.54 1.06 3.68 10.19 8.65 7.60
CWIP 0.00 0.00 0.30 0.42 0.00 0.00
Investments 0.00 0.00 0.00 33.19 59.09 64.22
22.98 32.82 181.77 175.33 138.85 137.17
Total Assets 23.52 33.88 185.75 219.13 206.59 208.99

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
0.31 -7.92 34.87 1.40 10.23
-0.12 -0.39 -110.04 -3.09 -16.47
-0.14 8.28 92.34 -7.30 -1.51
Net Cash Flow 0.04 -0.04 17.17 -8.99 -7.75

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 52.24 47.35 0.38 4.13 14.10
Inventory Days 123.18 92.82 134.95 173.89 166.63
Days Payable 88.73 32.94 32.07 12.99 24.11
Cash Conversion Cycle 86.70 107.24 103.26 165.02 156.61
Working Capital Days 44.70 85.39 61.75 110.76 160.43
ROCE % 56.69% 66.71% 32.61% -6.27%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
70.00% 70.00% 70.00% 70.00% 70.00% 70.00% 62.98% 62.98% 62.98% 63.24% 63.24% 63.24%
12.42% 13.57% 13.02% 12.22% 12.04% 1.67% 0.10% 0.10% 0.10% 0.10% 0.07% 0.07%
6.75% 5.52% 5.52% 5.23% 5.22% 0.55% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
10.83% 10.92% 11.47% 12.55% 12.74% 27.78% 36.92% 36.91% 36.92% 36.67% 36.69% 36.69%
No. of Shareholders 10,06012,61815,47126,12326,11463,91162,00758,56055,56952,25549,60045,996

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls

  • Feb 2024
    Transcript
    Notes
    PPT
  • Nov 2023
    Transcript
    Notes
    PPT
  • Aug 2023
    Transcript
    Notes
    PPT